2d:I[856015,["/_next/static/immutable/chunks/1xzisbplk9czp.js","/_next/static/immutable/chunks/3j2i1faptc_-9.js","/_next/static/immutable/chunks/0fma7nlq6immz.js","/_next/static/immutable/chunks/08tq8rmv423j5.js","/_next/static/immutable/chunks/1chr5wkk3j58k.js","/_next/static/immutable/chunks/37kmmh_zm4dov.js","/_next/static/immutable/chunks/311zvdjfxff-f.js","/_next/static/immutable/chunks/1a_hqhrsle_n_.js"],"default"] 2e:T5640,

Summary Table

Feature	Detail
Risk Factors	Maternal rubella infection during first trimester (highest risk < 12 weeks gestation); unvaccinated mother; travel to or residence in endemic regions; lack of prior immunity
Etiology	Transplacental transmission of rubella virus (Togavirus, single-stranded RNA) from a viremic mother to the fetus
Patient Presentation	Newborn with a combination of congenital heart defect, eye abnormalities, and sensorineural hearing loss; may also present with growth restriction, thrombocytopenic purpura, or hepatosplenomegaly
Classic Physical Exam	"Blueberry muffin" rash (dermal extramedullary hematopoiesis), cataracts (white reflex), microcephaly, jaundice, hepatosplenomegaly
Key Diagnostic Results	Rubella-specific IgM antibody in neonatal serum; persistent rubella IgG beyond 6 months of age; viral isolation from nasopharyngeal swab or urine
Management	No antiviral therapy exists. Supportive and multidisciplinary care: cardiac surgery for PDA/pulmonary stenosis, audiologic rehabilitation, ophthalmologic intervention. Prevention with MMR vaccination is the primary strategy.
Keywords	"Blueberry muffin baby," "PDA + cataracts + deafness," "first trimester maternal rash," "unvaccinated pregnant woman," "sensorineural hearing loss in a neonate"

1. Pathophysiology

Rubella virus belongs to the Togaviridae family and is transmitted via respiratory droplets. When a non-immune pregnant woman contracts rubella, the virus enters the bloodstream and crosses the placenta during the period of maternal viremia. The virus has a particular tropism for rapidly dividing fetal cells, which explains why the damage is most severe during organogenesis in the first trimester.

The mechanism of fetal injury is twofold. First, rubella virus causes direct cytopathic damage to endothelial cells lining fetal blood vessels. This vascular injury leads to ischemic damage in developing organs, particularly the heart, eyes, and inner ear. Second, the virus inhibits cellular mitosis, reducing the total cell number in affected organs and resulting in hypoplastic organ development. This is why affected neonates frequently exhibit intrauterine growth restriction and microcephaly.

The timing of maternal infection is the single most important determinant of severity. Infection before 12 weeks of gestation carries a risk of congenital defects exceeding 80%, because this window coincides with cardiac septation, lens formation, and cochlear development. Infection between 12 and 18 weeks still carries risk, primarily for sensorineural hearing loss (the organ of Corti is among the last structures to complete differentiation). After 20 weeks, the risk of congenital defects drops substantially because organogenesis is essentially complete.

The characteristic "blueberry muffin" rash is not a viral exanthem. It represents foci of dermal extramedullary hematopoiesis, a compensatory response to rubella-induced bone marrow suppression and thrombocytopenia. This finding is not exclusive to CRS (it also appears in CMV and other TORCH infections), but in the context of the classic triad, it is highly suggestive.

Infected neonates can shed the virus for months after birth (typically up to 12 months), making them a significant source of contagion to susceptible contacts, including pregnant healthcare workers.

2. Classification and Clinical Manifestation

Gregg Triad

Component	Detail
Congenital heart disease	Patent ductus arteriosus (PDA) is the most common cardiac lesion; pulmonary artery stenosis is the most characteristic (almost pathognomonic for CRS among TORCH infections)
Eye abnormalities	Cataracts (bilateral, dense, nuclear type); may also see microphthalmos, pigmentary retinopathy ("salt-and-pepper" retinopathy), and glaucoma
Sensorineural hearing loss	The most common single manifestation of CRS; may be the only finding in cases of second-trimester infection; bilateral, often progressive

Other Manifestations

Category	Findings
Neurologic	Microcephaly, psychomotor retardation, meningoencephalitis, behavioral disorders
Hematologic	Thrombocytopenia, hemolytic anemia, "blueberry muffin" spots (dermal extramedullary hematopoiesis)
Hepatic	Hepatosplenomegaly, conjugated hyperbilirubinemia, elevated transaminases
Skeletal	Radiolucent bone lesions ("celery stalking" of long bone metaphyses)
Endocrine (late)	Insulin-dependent diabetes mellitus and thyroid dysfunction can appear in adolescence or adulthood as delayed autoimmune consequences
Growth	Intrauterine growth restriction, low birth weight

Severity by Timing of Maternal Infection

GA at infection	Risk of Congenital Defects	Predominant Findings
< 8 weeks	> 85%	Full triad: cardiac + ocular + auditory
8 to 12 weeks	50 to 80%	Deafness + cardiac defects
13 to 18 weeks	15 to 30%	Sensorineural hearing loss predominates
> 20 weeks	Rare	Generally no structural defects

3. Diagnostic Workup

Test	Role	Key Findings
Rubella-specific IgM (neonatal serum)	Best initial test	Positive IgM in the neonate indicates active/recent fetal infection (IgM does not cross the placenta)
Rubella-specific IgG (serial)	Confirmatory / supportive	Persistently elevated IgG beyond 6 to 8 months of age (when maternal IgG should have waned) confirms congenital infection
Rubella viral culture / RT-PCR	Most accurate test	Isolation of rubella virus from nasopharyngeal swab, urine, or CSF; RT-PCR is the modern gold standard for direct viral detection
CBC	Supportive	Thrombocytopenia, anemia
Echocardiography	Organ-targeted	PDA, pulmonary artery stenosis, septal defects
Ophthalmologic exam	Organ-targeted	Cataracts, pigmentary retinopathy, glaucoma
Auditory brainstem response (ABR)	Organ-targeted	Sensorineural hearing loss
Head imaging (CT/MRI)	If neurologic concern	Intracranial calcifications (periventricular, though less prominent than CMV), microcephaly

Diagnostic reasoning: The single most important initial test in a neonate suspected of CRS is rubella-specific IgM. Because IgM antibodies cannot cross the placenta, a positive neonatal IgM is direct evidence of fetal infection. This distinguishes active congenital infection from passive transfer of maternal IgG.

If IgM is equivocal or the clinical picture is ambiguous, serial IgG titers become valuable. Normally, passively transferred maternal IgG declines and disappears by 6 to 8 months of age. If the infant's rubella IgG remains elevated or fails to decline, this confirms endogenous antibody production due to congenital infection.

For definitive virologic confirmation, RT-PCR or viral isolation from nasopharyngeal secretions, urine, or lens aspirate is the most accurate method. This also has public health importance because a positive culture means the infant is actively shedding virus and must be isolated from susceptible individuals.

Organ-targeted workup (echocardiography, ABR, ophthalmologic examination) should be performed in every confirmed case, even if the presenting complaint involves only one organ system, because subclinical involvement of other systems is common.

4. Management and Treatment

Phase	Intervention	Details
Acute neonatal	Supportive care	Manage thrombocytopenia (platelet transfusion if bleeding), treat hyperbilirubinemia, nutritional support
Cardiac	Surgical correction	PDA ligation or transcatheter closure; repair of pulmonary artery stenosis if hemodynamically significant
Ophthalmologic	Cataract extraction	Early removal to prevent deprivation amblyopia; may require intraocular lens implantation or aphakic correction
Audiologic	Hearing rehabilitation	Hearing aids, cochlear implantation if profound bilateral sensorineural hearing loss; early intervention for speech and language development
Neurodevelopmental	Early intervention services	Physical therapy, occupational therapy, special education as needed
Endocrine (long-term)	Screening	Monitor for insulin-dependent diabetes mellitus and thyroid dysfunction into adolescence and adulthood
Infection control	Isolation	Infant considered contagious for up to 12 months; isolate from pregnant women and immunocompromised individuals
Prevention	MMR vaccination	Two doses (first at 12 to 15 months, second at 4 to 6 years); women of childbearing age should be screened for rubella immunity; if non-immune, vaccinate at least 4 weeks before conception; MMR is contraindicated during pregnancy (live vaccine)

There is no antiviral therapy for CRS. Management is entirely supportive and multidisciplinary. The exam will almost never ask you to "treat" CRS pharmacologically. Instead, the testable angle is prevention through vaccination.

The most high-yield management concept is the pre-conception vaccination strategy. A woman found to be rubella non-immune during preconception counseling or early prenatal screening should receive MMR vaccine and be advised to avoid pregnancy for at least 4 weeks after vaccination. If a pregnant woman is found to be non-immune, she cannot be vaccinated during pregnancy because MMR is a live attenuated vaccine. She should be vaccinated immediately postpartum to protect future pregnancies.

For cardiac lesions, PDA is the most commonly tested surgical intervention. If the PDA is hemodynamically significant (wide pulse pressure, continuous "machinery" murmur, signs of heart failure), the next best step is echocardiographic confirmation followed by surgical ligation or transcatheter closure.

Early cataract removal (within the first few weeks of life) is critical to prevent irreversible deprivation amblyopia. Delay in surgery leads to permanent visual impairment even if the cataract is later removed.

5. Differential Diagnosis and Distractors

Differential Diagnosis	Why It Is Similar	Key Discriminator
Congenital CMV	Also a TORCH infection; also causes microcephaly, hepatosplenomegaly, thrombocytopenia, blueberry muffin rash, sensorineural hearing loss	CMV produces periventricular calcifications (rubella calcifications are less prominent); CMV causes chorioretinitis rather than cataracts; CMV is the most common congenital infection overall; CMV does not typically cause congenital heart defects
Congenital Toxoplasmosis	Triad of chorioretinitis, hydrocephalus, intracranial calcifications; also causes hepatosplenomegaly	Toxoplasmosis has diffuse/scattered intracranial calcifications and hydrocephalus (not microcephaly); the eye finding is chorioretinitis, not cataracts; no cardiac involvement
Congenital Syphilis	Hepatosplenomegaly, rash, bony abnormalities, growth restriction	Syphilis produces rhinitis (snuffles), mucocutaneous lesions, periostitis/osteochondritis, and positive RPR/VDRL with confirmatory FTA-ABS; no cataracts or PDA
Neonatal Herpes (HSV)	Vesicular rash, hepatitis, encephalitis in a neonate	HSV presents with grouped vesicles, often localized to skin/eye/mouth or disseminated with hemorrhagic hepatitis; transmission is typically intrapartum (not transplacental); no cardiac or ocular structural defects
Congenital Zika	Microcephaly, ocular abnormalities, arthrogryposis	Zika causes severe microcephaly with brain disruption sequence, macular scarring, and limb contractures; no PDA; epidemiologic link to Zika-endemic areas

The most commonly confused pair on exams is CRS vs. Congenital CMV. Both can produce hearing loss, blueberry muffin rash, hepatosplenomegaly, and microcephaly. The key discriminators are:

Cataracts + PDA = CRS
Chorioretinitis + periventricular calcifications = CMV

A vignette that mentions a congenital heart defect (especially PDA or pulmonary artery stenosis) alongside eye findings and deafness is pointing squarely at rubella.

6. Traps and High-Yield Pearls

The most common trap with CRS questions is confusing it with congenital CMV. Both are TORCH infections with overlapping features, and the vignette may include shared findings like hepatosplenomegaly, thrombocytopenia, and hearing loss. The discriminator the test-writer plants in the stem is the type of eye finding (cataracts for rubella, chorioretinitis for CMV) and the presence of a congenital heart defect (strongly favors rubella).

Another frequently tested trap involves management of rubella exposure during pregnancy. Students sometimes select "give MMR vaccine" when a pregnant woman is exposed to rubella. This is wrong. MMR is a live vaccine and is absolutely contraindicated in pregnancy. The correct answer for a susceptible pregnant woman exposed to rubella is rubella-specific immunoglobulin (IG) for passive immunization, followed by MMR vaccination postpartum. If the vignette describes a non-immune woman who is not yet pregnant, the answer is to vaccinate now and advise contraception for at least 4 weeks.

Students also overlook the fact that sensorineural hearing loss is the single most common manifestation of CRS and may be the only finding if infection occurred in the second trimester. A vignette describing isolated bilateral sensorineural hearing loss in an infant born to a mother with a first-trimester rash illness should trigger consideration of CRS even without cardiac or ocular findings.

Finally, remember the late manifestations. CRS is not a static condition. Patients can develop insulin-dependent diabetes mellitus and thyroid disease years to decades later, presumably through autoimmune mechanisms triggered by persistent viral antigen. If a question describes a young adult with type 1 diabetes and a history of congenital cataracts or hearing loss, connect the dots back to CRS.

The core competency being tested is the ability to recognize the classic triad, correctly assign it to rubella (not CMV or toxoplasmosis), understand that prevention through vaccination is the cornerstone of management, and recall the contraindication of live vaccines in pregnancy.

1e:["$","$L2d",null,{"article":{"id":"4db84dac-91c4-441c-b6e6-16ca240fd4d3","title":"Rubella pada Kehamilan","content":"$2e","category":"Reproduksi","created_at":"2026-05-16T10:37:30.923008+00:00","status":"published","subcategory":null},"questionCount":1,"sections":[{"id":"section-pathophysiology","num":"01","title":"Pathophysiology"},{"id":"section-classification-and-clinical-manifestation","num":"02","title":"Classification and Clinical Manifestation"},{"id":"section-diagnostic-workup","num":"03","title":"Diagnostic Workup"},{"id":"section-management-and-treatment","num":"04","title":"Management and Treatment"},{"id":"section-differential-diagnosis-and-distractors","num":"05","title":"Differential Diagnosis and Distractors"},{"id":"section-traps-and-high-yield-pearls","num":"06","title":"Traps and High-Yield Pearls"}],"hasSummaryTable":true}]